Akso Health Group ADR (AHG) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Akso Health Group ADR (AHG) has a cash flow conversion efficiency ratio of 0.015x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($3.01 Million) by net assets ($199.15 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Akso Health Group ADR - Cash Flow Conversion Efficiency Trend (2015–2025)
This chart illustrates how Akso Health Group ADR's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Akso Health Group ADR balance sheet liabilities for a breakdown of total debt and financial obligations.
Akso Health Group ADR Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Akso Health Group ADR ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Run Long Construction Co Ltd
TW:1808
|
0.308x |
|
Shenzhen Prince New Materials Co Ltd
SHE:002735
|
0.019x |
|
Shanxi Huhua Group Co Ltd
SHE:003002
|
0.019x |
|
Shanghai Urban Architecture Design Co. Ltd.
SHE:300983
|
N/A |
|
Tae Kwang Corporation
KQ:023160
|
0.005x |
|
Shanghai Maling Aquarius Co Ltd
SHG:600073
|
0.129x |
|
Costar Group Co Ltd
SHE:002189
|
0.004x |
|
Johns LYNG Group Ltd
AU:JLG
|
0.096x |
Annual Cash Flow Conversion Efficiency for Akso Health Group ADR (2015–2025)
The table below shows the annual cash flow conversion efficiency of Akso Health Group ADR from 2015 to 2025. For the full company profile with market capitalisation and key ratios, see Akso Health Group ADR (AHG) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | $199.15 Million | $1.18 Million | 0.006x | -39.45% |
| 2024-03-31 | $138.42 Million | $1.35 Million | 0.010x | +102.65% |
| 2023-03-31 | $8.84 Million | $-3.25 Million | -0.368x | +47.60% |
| 2022-03-31 | $12.29 Million | $-8.63 Million | -0.702x | -220.60% |
| 2021-03-31 | $17.27 Million | $10.06 Million | 0.582x | +150.14% |
| 2020-03-31 | $48.10 Million | $-55.87 Million | -1.161x | -8387.46% |
| 2019-03-31 | $126.50 Million | $-1.73 Million | -0.014x | -102.18% |
| 2018-03-31 | $140.04 Million | $87.72 Million | 0.626x | +79.78% |
| 2017-03-31 | $23.50 Million | $8.19 Million | 0.348x | -30.51% |
| 2016-03-31 | $14.01 Million | $7.03 Million | 0.501x | -35.05% |
| 2015-03-31 | $3.35 Million | $2.59 Million | 0.772x | -- |
About Akso Health Group ADR
Akso Health Group, together with its subsidiaries, operates a social e-commerce mobile platform in the People's Republic of China. It operates Xiaobai Maimai App, a social e-commerce mobile platform that offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, and cost-saving promotions at petrol gas stations. The compan… Read more